Please Wait
Applying Filters...
menu
    • menu
    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    ASLAN004

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    ASLAN's Enrolls First Patient in Proof-of-Concept Study for ASLAN004
    ASLAN's Enrolls First Patient in Proof-of-Concept Study for ASLAN004

    21 Oct 2019

    // BIOSPACE

    https://www.biospace.com/article/releases/aslan-pharmaceuticals-enrolls-first-patient-in-proof-of-concept-study-for-aslan004-targeting-atopic-dermatitis/

    BIOSPACE
    21 Oct 2019
    Share Share
    Aslan retools CSL deal, taking control of would-be Dupixent rival
    Aslan retools CSL deal, taking control of would-be Dupixent rival

    03 Jun 2019

    // Nick Paul Taylor FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/aslan-retools-csl-deal-taking-control-would-be-dupixent-rival

    Nick Paul Taylor FIERCE BIOTECH
    03 Jun 2019
    Share Share
    Aslan Pharmaceuticals Acquires Full Global Commercial Rights For Aslan004
    Aslan Pharmaceuticals Acquires Full Global Commercial Rights For Aslan004

    01 Jun 2019

    // BIOSPACE

    https://www.biospace.com/article/aslan-pharmaceuticals-acquires-full-global-commercial-rights-for-aslan004-from-csl/?s=79

    BIOSPACE
    01 Jun 2019
    Share Share